The many faces of macrophage activation
暂无分享,去创建一个
[1] J. Ihle,et al. Cutting Edge: Stat6-Dependent Substrate Depletion Regulates Nitric Oxide Production1 , 2001, The Journal of Immunology.
[2] B. Antus,et al. Influence of alternatively and classically activated macrophages on fibrogenic activities of human fibroblasts. , 2000, Cellular immunology.
[3] J. Hibbs. Infection and nitric oxide. , 2002, The Journal of infectious diseases.
[4] A. Ho,et al. Interleukin-10 and its receptor. , 1994, Therapeutic immunology.
[5] S. Kinare,et al. Association of lung carcinoma and tuberculosis. , 1991, Journal of postgraduate medicine.
[6] P. De Baetselier,et al. Differential expression of FIZZ1 and Ym1 in alternatively versus classically activated macrophages , 2002, Journal of leukocyte biology.
[7] S. Goerdt,et al. Alternatively activated macrophages actively inhibit proliferation of peripheral blood lymphocytes and CD4+ T cells in vitro , 1997, Immunology.
[8] S. Gordon,et al. Alterations of surface properties by macrophage activation: expression of receptors for Fc and mannose-terminal glycoproteins and differentiation antigens. , 1984, Contemporary topics in immunobiology.
[9] J. Gerber,et al. Reversing lipopolysaccharide toxicity by ligating the macrophage Fc gamma receptors. , 2001, Journal of immunology.
[10] C. Nathan. Mechanisms and modulation of macrophage activation. , 1991, Behring Institute Mitteilungen.
[11] S. Reed. TGF-beta in infections and infectious diseases. , 1999, Microbes and infection.
[12] D. Mosser,et al. Treatment of murine macrophages with interferon‐γ inhibits their ability to bind leishmania promastigotes , 1992, Journal of leukocyte biology.
[13] S. Goerdt,et al. Alternatively Activated Macrophages Differentially Express Fibronectin and Its Splice Variants and the Extracellular Matrix Protein βIG‐H3 , 2001, Scandinavian journal of immunology.
[14] L. Ting,et al. Mycobacterium tuberculosis inhibits IFN-gamma transcriptional responses without inhibiting activation of STAT1. , 1999, Journal of immunology.
[15] Ho As,et al. Interleukin-10 and its receptor. , 1994 .
[16] E. Pearce,et al. Differential Regulation of Nitric Oxide Synthase-2 and Arginase-1 by Type 1/Type 2 Cytokines In Vivo: Granulomatous Pathology Is Shaped by the Pattern of l-Arginine Metabolism1 , 2001, The Journal of Immunology.
[17] F. Sutterwala,et al. Reversal of Proinflammatory Responses by Ligating the Macrophage Fcγ Receptor Type I , 1998, The Journal of experimental medicine.
[18] S Gordon,et al. Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation , 1992, The Journal of experimental medicine.
[19] N. Reiner,et al. Exploitation of host cell signaling machinery: activation of macrophage phosphotyrosine phosphatases as a novel mechanism of molecular microbial pathogenesis , 2000, Journal of leukocyte biology.
[20] Kristi Kincaid,et al. M-1/M-2 Macrophages and the Th1/Th2 Paradigm1 , 2000, The Journal of Immunology.
[21] David M. Mosser,et al. Cutting Edge: Biasing Immune Responses by Directing Antigen to Macrophage Fcγ Receptors1 , 2002, The Journal of Immunology.
[22] J. Gerber,et al. Reversing Lipopolysaccharide Toxicity by Ligating the Macrophage Fcγ Receptors1 , 2001, The Journal of Immunology.
[23] D. Mosser,et al. Cutting edge: biasing immune responses by directing antigen to macrophage Fc gamma receptors. , 2002, Journal of immunology.
[24] S. Goerdt,et al. Other functions, other genes: alternative activation of antigen-presenting cells. , 1999, Immunity.
[25] P. H. Correll,et al. Activation of the Stem Cell-Derived Tyrosine Kinase/RON Receptor Tyrosine Kinase by Macrophage-Stimulating Protein Results in the Induction of Arginase Activity in Murine Peritoneal Macrophages1 , 2002, The Journal of Immunology.
[26] D. Mosser,et al. A novel phenotype for an activated macrophage: the type 2 activated macrophage , 2002, Journal of leukocyte biology.
[27] F. Sutterwala,et al. Selective Suppression of Interleukin-12 Induction after Macrophage Receptor Ligation , 1997, The Journal of experimental medicine.
[28] T. Gingeras,et al. Reprogramming of the macrophage transcriptome in response to interferon-gamma and Mycobacterium tuberculosis: signaling roles of nitric oxide synthase-2 and phagocyte oxidase. , 2001, The Journal of experimental medicine.
[29] S. Goerdt,et al. Alternative macrophage activation-associated CC-chemokine-1, a novel structural homologue of macrophage inflammatory protein-1 alpha with a Th2-associated expression pattern. , 1998, Journal of immunology.
[30] M. Modolell,et al. Reciprocal regulation of the nitric oxide synthase/arginase balance in mouse bone marrow‐derived macrophages by TH 1 and TH 2 cytokines , 1995, European journal of immunology.
[31] P. Gros,et al. Genetic susceptibility to intracellular infections: Nramp1, macrophage function and divalent cations transport. , 2000, Current opinion in microbiology.
[32] C. Nathan,et al. Nitric oxide and macrophage function. , 1997, Annual review of immunology.
[33] Kinare Sg,et al. Association of lung carcinoma and tuberculosis. , 1991 .
[34] R. Flavell. The relationship of inflammation and initiation of autoimmune disease: role of TNF super family members. , 2002, Current topics in microbiology and immunology.
[35] T. Gingeras,et al. Reprogramming of the Macrophage Transcriptome in Response to Interferon-γ and Mycobacterium tuberculosis , 2001, The Journal of experimental medicine.
[36] V. Fadok,et al. Phosphatidylserine-dependent ingestion of apoptotic cells promotes TGF-beta1 secretion and the resolution of inflammation. , 2002, The Journal of clinical investigation.
[37] E. Borden,et al. Interferon‐lnduced Indoleamine 2,3‐Dioxygenase Activity in Human Mononuclear Phagocytes , 1989, Journal of leukocyte biology.
[38] Constantin E. Orfanos,et al. Alternative versus Classical Activation of Macrophages , 2000, Pathobiology.
[39] S. Reed. TGF-β in infections and infectious diseases , 1999 .